您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > (±)-JWH 398 N-(4-hydroxypentyl)metabolite-d5
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
(±)-JWH 398 N-(4-hydroxypentyl)metabolite-d5
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
(±)-JWH 398 N-(4-hydroxypentyl)metabolite-d5图片
规格:98%
分子量:396.9
包装与价格:
包装价格(元)
500ug电议
1mg电议

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx20874
CAS:N/A
分子式:C24H17ClD5NO2
分子量:396.9
溶解度:DMF: 20 mg/ml,DMSO: 25 mg/ml,Ethanol: 15 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

JWH 398 is a synthetic cannabinoid (CB) that activates both central CB1and peripheral CB2receptors (Ki= 2.3 and 2.8 nM, respectively).1It has been reported to be an adulterant of herbal products.2,3(±)-JWH 398 N-(4-hydroxypentyl) metabolite is an expected phase I metabolite of JWH 398 , detectable in serum and urine. While similar hydroxylated phase I metabolites of synthetic CBs retain activity, the physiological properties of this compound have yet to be determined.4,5This product is intended for research and forensic applications. (±)-JWH 398 N-(4-hydroxypentyl) metabolite-d5contains five deuterium atoms at the 2, 4, 5, 6, and 7 positions. It is intended for use as an internal standard for the quantification of JWH 398 N-(4-hydroxypentyl) metabolite by GC-or LC-mass spectrometry.


1.Huffman, J.W.Cannabimimetic indoles, pyrroles, and indenes: Structure-activity relationships and receptor interactionsThe cannabinoid receptors49-95(2009) 2.Kikura-Hanajiri, R., Uchiyama, N., and Goda, Y.Survey of current trends in the abuse of psychotropic substances and plants in JapanLeg. Med. (Tokyo)13(3)109-115(2011) 3.Dresen, S., FerreirÓs, N., PÜtz, M., et al.Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compoundsJournal of Mass Spectrometry45(10)1186-1194(2010) 4.Brents, L.K., Reichard, E.E., Zimmerman, M., et al.Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activityPLoS One6(7)1-9(2011) 5.Brents, L.K., Gallus-Zawala, A., Radominska-Pandya, A., et al.Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retainintermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutralantagonist to partial agonist activityBiochemical Pharmacology83952-961(2012)